Close

People

Jennifer Stewart is a partner in the San Francisco office of King & Spalding and a member of the firm's Trial and Global Disputes practice group. Her practice focuses on defending companies in the pharmaceutical, medical device, consumer products, and biotech industries in nationwide product liability and mass tort litigation.  She has over a decade of experience litigating civil cases in state and federal courts across the country, including in multidistrict litigation (MDL) and coordinated state court proceedings, from pre-suit investigation through trial and appeal.  

Jennifer has an extensive trial practice, having achieved successful outcomes for her clients in nine jury trials, serving as second-chair in five of those trials. 

For the last four years, Jennifer has been selected by her peers for inclusion in Best Lawyers: Ones to Watch in America for Product Liability Litigation. 

Aside from her product liability and mass tort practice, Jennifer has litigated numerous business matters in various substantive areas of law, including trade secrets misappropriation, unlawful business practices, unfair competition, and other high-stakes business disputes.  Jennifer is also dedicated to pro bono work, and an active member of the firm's Women's Affinity Group. 

Prior to joining King & Spalding, Jennifer spent several years as an associate at a business litigation firm in New York City, where she was a member of litigation and trial teams, defending Fortune 100 companies in product liability and toxic tort cases.

Jennifer obtained her Juris Doctor from The Catholic University of America, Columbus School of Law. In law school, she served as the senior note and comment editor for the Commlaw Conspectus: Journal of Communications Law and Policy.

Full Bio

Credentials

J.D., Columbus School of Law

B.A., Boston University, cum laude

California

New Jersey

New York

U.S. District Court for the Central District of California

U.S. District Court for the District of New Jersey

U.S. District Court for the Southern District of New York

News

In the News · Source: Law.com, The Global Legal Post, Global Arbitration Review, IJGlobal, The Deal, Law360 Pulse, Australasian Lawyer, The Daily Report, Le Monde du Droit and La Lettre des Juristes d'Affaires

December 8, 2022
K&S elects 24 new partners and promotes 17 counsel across 15 cities

View all

Matters

Represent Walmart in multi-district litigation (MDL) alleging that prenatal ingestion of acetaminophen leads to ADHD and ASD in children.

Represent a multinational pharmaceutical and biotechnology company in defense of product liability claims relating to the use of a herbicide, with responsibility for the management of aggregate settlements involving thousands of claimants.

Represented a large international medical device company in its nationwide female pelvic mesh litigation.

See more

Close

Matters

Represent Walmart in multi-district litigation (MDL) alleging that prenatal ingestion of acetaminophen leads to ADHD and ASD in children.

Represent a multinational pharmaceutical and biotechnology company in defense of product liability claims relating to the use of a herbicide, with responsibility for the management of aggregate settlements involving thousands of claimants.

Represented a large international medical device company in its nationwide female pelvic mesh litigation.

Represented a technology company in defending unfair competition/predatory pricing claims by a competitor.

Trial counsel for Johnson & Johnson in two high-profile product liability cases claiming the company's talcum powder products caused the plaintiff's mesothelioma.

Represented AstraZeneca Pharmaceuticals LP in coordinated California state court product liability cases related to treatment with Crestor®.

Defended Bristol-Myers Squibb Company and AstraZeneca Pharmaceuticals LP in litigation in state and federal courts related to treatment with Onglyza®, a type 2 diabetes therapy.

Represented Fortune 100 companies in products matters involving alleged harm as a result of exposure to asbestos. Jennifer has experience in handling all aspects of these cases and, as such, has secured dismissals or favorable settlements for her clients.

Represented a Fortune 500 company in construction case involving violations of state labor laws.

Represented client in defense of misappropriation of trade secrets and conversion claims, leading to dismissal of case on appeal.

News

In the News · Source: Law.com, The Global Legal Post, Global Arbitration Review, IJGlobal, The Deal, Law360 Pulse, Australasian Lawyer, The Daily Report, Le Monde du Droit and La Lettre des Juristes d'Affaires

December 8, 2022
K&S elects 24 new partners and promotes 17 counsel across 15 cities

View all

Matters

Represent Walmart in multi-district litigation (MDL) alleging that prenatal ingestion of acetaminophen leads to ADHD and ASD in children.

Represent a multinational pharmaceutical and biotechnology company in defense of product liability claims relating to the use of a herbicide, with responsibility for the management of aggregate settlements involving thousands of claimants.

Represented a large international medical device company in its nationwide female pelvic mesh litigation.

See more

Close

Matters

Represent Walmart in multi-district litigation (MDL) alleging that prenatal ingestion of acetaminophen leads to ADHD and ASD in children.

Represent a multinational pharmaceutical and biotechnology company in defense of product liability claims relating to the use of a herbicide, with responsibility for the management of aggregate settlements involving thousands of claimants.

Represented a large international medical device company in its nationwide female pelvic mesh litigation.

Represented a technology company in defending unfair competition/predatory pricing claims by a competitor.

Trial counsel for Johnson & Johnson in two high-profile product liability cases claiming the company's talcum powder products caused the plaintiff's mesothelioma.

Represented AstraZeneca Pharmaceuticals LP in coordinated California state court product liability cases related to treatment with Crestor®.

Defended Bristol-Myers Squibb Company and AstraZeneca Pharmaceuticals LP in litigation in state and federal courts related to treatment with Onglyza®, a type 2 diabetes therapy.

Represented Fortune 100 companies in products matters involving alleged harm as a result of exposure to asbestos. Jennifer has experience in handling all aspects of these cases and, as such, has secured dismissals or favorable settlements for her clients.

Represented a Fortune 500 company in construction case involving violations of state labor laws.

Represented client in defense of misappropriation of trade secrets and conversion claims, leading to dismissal of case on appeal.

News

In the News · Source: Law.com, The Global Legal Post, Global Arbitration Review, IJGlobal, The Deal, Law360 Pulse, Australasian Lawyer, The Daily Report, Le Monde du Droit and La Lettre des Juristes d'Affaires

December 8, 2022
K&S elects 24 new partners and promotes 17 counsel across 15 cities

View all

Credentials

J.D., Columbus School of Law

B.A., Boston University, cum laude

California

New Jersey

New York

U.S. District Court for the Central District of California

U.S. District Court for the District of New Jersey

U.S. District Court for the Southern District of New York